MedTrace Logo

Ex Vivo Evaluation on Human Tissue of the Binding of Experimental Radiolabeled Ligands

NCT07047677 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-07-18

No results posted yet for this study

Summary

The HERO project aims to structure an ex vivo screening platform, based on anonymized human tissues, to early assess the tissue fixation of experimental ligands in an ethical, translational approach that complies with the principles of the 3Rs (Replacement, Reduction, Refinement).

Conditions

  • Tissue Model

Interventions

OTHER

Early assessment of tissue uptake of experimental ligands

Ex vivo evaluation of the binding of experimental radiolabeled ligands on human tissue using autohistoradiography

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-01-01
Completion
2030-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07047677 on ClinicalTrials.gov